drugset / Trial / NCT02475746

An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects

NCT02475746

Phase 1 Withdrawn Pfizer
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of itraconazole after multiple dose administration on the single dose PK of PF-06372865.

Timeline

Start
2015-07
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Darigabat Small molecule 7.5 mg
Subject Itraconazole Small molecule 200 mg

Indications

No indication recorded.